Fisher And Paykel Healthcare Corpo revenue and financials
$37.69Change from previous close: +0.96%Absolute change: +$0.36
In the fiscal year ended March 2026, Fisher And Paykel Healthcare Corpo reported revenue of $2.31B (+80.30% year over year). Net income was $468.5M, a net margin of 20.3%.
Fiscal year ending in March. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +80.30%
- FY to Mar 2026 vs FY to Mar 2025
- Net income growth
- +24.20%
- FY to Mar 2026 vs FY to Mar 2025
- Net margin
- 20.3%
- FY to Mar 2025: 29.5%
Financial data
Amounts in millions of NZD; per-share values in NZD; shares in millions.
| Item | Q1 2025 |
|---|---|
| Capital expenditure | -103 |
| Investing cash flow | -103 |
| Financing cash flow | -268 |
| Dividends paid | -196 |
| Debt issued | 107 |
| Debt repaid | -164 |
| Effect of exchange rates | 1.9 |
| Net change in cash | 177 |
| Free cash flow | 446 |